IMRSQ Imris Inc (CE)

 

---

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of May 2015

Commission File Number: 001-34975

IMRIS INC.
(Translation of registrant's name into English)

100-1370 Sony Place, Winnipeg, Manitoba, Canada R3T 1N5
(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

☐ Form 20-F

☒ Form 40-F

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨

---

 

 

 

DOCUMENTS FILED AS PART OF THIS FORM 6-K

 

See the Exhibit Index hereto.

 

---

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

	IMRIS Inc.
	(Registrant)
Date: May 6, 2015	By:	/s/ Jay D. Miller
		_____________________________________
	Name:	Jay D. Miller
	Title:	President and CEO

 

---

 

EXHIBIT INDEX

99.1	Material Change Report
99.2	News Release Dated May 7, 2015 - IMRIS Announces Correction of Annual Meeting Record Date to May 15, 2015

 

 

---

 

Exhibit 99.1

 

 

FORM 51-102F3

Material Change Report

 

Item 1		Name and Address of Company
		IMRIS Inc. (the “Company”)
		5101 Shady Oak Rd
		Minnetonka, Minnesota
		55343
Item 2		Date of Material Change
		May 7, 2015
Item 3		News Release
		The news release attached as Schedule “A” was disseminated on May 7, 2015, as a correction to the news release disseminated on May 6, 2015. This material change report has been re-filed to reflect that correction.
Item 4		Summary of Material Change
		On May 7, 2015, the Company announced a correction to its press release issued on May 6, 2015, to correct the record date for the Company’s annual meeting of shareholders to be held on June 25, 2015.  The correct record date is May 15, 2015.
Item 5		Full Description of Material Change

 

 

		5.1	Full Description of Material Change
		For a full description of the material change, please refer to the news release attached as Schedule “A” hereto.
		5.2	Disclosure for Restructuring Transactions
		N/A

 

Item 6		Reliance on subsection 7.1(2) or (3) of National Instrument 51-102
		N/A
Item 7		Omitted Information
		N/A
Item 8		Executive Officer

 

		Name of Executive Officer:	Jay D. Miller
		Title:	President and CEO
		Telephone Number:	763-203-6300

 

Item 9		Date of Report
		May 7, 2015

 

 

Schedule “A”

 

 

 

IMRIS Announces Correction of Annual Meeting Record Date to May 15, 2015

 

MINNEAPOLIS, May 7, 2015 – IMRIS Inc. (NASDAQ: IMRS; TSX: IM) (“IMRIS” or the “Company”) announces a correction to yesterday’s press release which stated that the Company's shareholders of record on May 14, 2015 will be entitled to notice and to vote at the Annual Meeting. The record date is May 15, 2015 instead of May 14, 2015.

 

About IMRIS

 

IMRIS (NASDAQ: IMRS; TSX: IM) is a global leader in providing image guided therapy solutions through its VISIUS Surgical Theatre – a revolutionary, multifunctional surgical environment that provides unmatched intraoperative vision to clinicians to assist in decision making and enhance precision in treatment. The multi-room suites incorporate diagnostic quality high-field MR, CT and angio modalities accessed effortlessly in the operating room setting. VISIUS Surgical Theatres serve the neurosurgical, spinal, cardiovascular and cerebrovascular markets and have been selected by leading medical institutions around the world.

 

Cautionary Note Regarding Forward-Looking Statements

This press release may contain or refer to forward-looking information based on current expectations, including but not limited to such matters as anticipated business prospects, economic and market conditions, financial condition and performance and other corporate affairs. In some cases, forward-looking statements can be identified by terminology such as “anticipate”, “may”, “expect”, “believe”, “prospective”, “continue” or the negative of these terms or other similar expressions concerning matters that are not historical facts. These statements should not be understood as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management's reasonable assumptions, there can be no assurance that actual results will be consistent with such statements. Forward-looking statements are subject to significant risks and uncertainties, and other factors that could cause actual results to differ materially from expected results, including but not limited to such risks that. These forward looking statements are made as of the date hereof and we assume no responsibility to update or revise them to reflect new events or circumstances.

 

For further information, please contact:

 

Jay Miller

President and Chief Executive Officer

IMRIS Inc.

Tel: 763-203-6303

Email: jmiller@imris.com

Exhibit 99.2

 

IMRIS Announces Correction of Annual Meeting Record Date to May 15, 2015

MINNEAPOLIS, May 7, 2015 /CNW/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") announces a correction to yesterday's press release which stated that the Company's shareholders of record on May 14, 2015 will be entitled to notice and to vote at the Annual Meeting.  The record date is May 15, 2015 instead of May 14, 2015.

About IMRIS

IMRIS (NASDAQ: IMRS; TSX: IM) is a global leader in providing image guided therapy solutions through its VISIUS Surgical Theatre – a revolutionary, multifunctional surgical environment that provides unmatched intraoperative vision to clinicians to assist in decision making and enhance precision in treatment. The multi-room suites incorporate diagnostic quality high-field MR, CT and angio modalities accessed effortlessly in the operating room setting. VISIUS Surgical Theatres serve the neurosurgical, spinal, cardiovascular and cerebrovascular markets and have been selected by leading medical institutions around the world.

Cautionary Note Regarding Forward-Looking Statements

This press release may contain or refer to forward-looking information based on current expectations, including but not limited to such matters as anticipated business prospects, economic and market conditions, financial condition and performance and other corporate affairs. In some cases, forward-looking statements can be identified by terminology such as "anticipate", "may", "expect", "believe", "prospective", "continue" or the negative of these terms or other similar expressions concerning matters that are not historical facts. These statements should not be understood as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management's reasonable assumptions, there can be no assurance that actual results will be consistent with such statements. Forward-looking statements are subject to significant risks and uncertainties, and other factors that could cause actual results to differ materially from expected results, including but not limited to such risks that. These forward looking statements are made as of the date hereof and we assume no responsibility to update or revise them to reflect new events or circumstances.

SOURCE IMRIS Inc.

 

%CIK: 0001489161

 

For further information: please contact: Jay Miller, President and Chief Executive Officer, IMRIS Inc., Tel: 763-203-6303, Email: jmiller@imris.com

CO: IMRIS Inc.

CNW 16:31e 07-MAY-15